Literature DB >> 26208471

Genetics of Cushing's disease: an update.

L G Perez-Rivas1, M Reincke2.   

Abstract

INTRODUCTION: Cushing's disease (CD) results from uncontrolled hypercortisolism induced by ACTH-secreting corticotroph adenomas; accordingly, patients diagnosed with CD usually present several comorbidities and an increased risk of mortality. Hypothesis-driven screenings have led to identification of rare alterations in a low number of patients, although the genetic basis underlying CD has remained unclear until recently. Using whole-exome sequencing, recurrent mutations have been reported in the gene coding for the ubiquitin-specific protease 8 (USP8), a protein with deubiquitinase (DUB) activity that modulates the lysosomal turnover of the EGF receptor (EGFR) and other membrane proteins.
METHODS: In this review, we summarize the recent genetic findings and discuss the clinical and pathological implications of USP8 deregulation in corticotroph adenomas.
CONCLUSIONS: Mutations in USP8 have been identified in 35-62 % of functional sporadic corticotroph adenomas causing Cushing's disease, but not in any other type of pituitary tumor. These mutations are found mostly in adult female patients and lead to an aberrant DUB activation by impairing the regulation of USP8 by members of the 14-3-3 family of proteins. The consequence of this hyperactivation is a longer retention of EGFR at the plasma membrane which promotes an enhanced production of ACTH.

Entities:  

Keywords:  ACTH; Cushing’s disease; EGFR; Pituitary tumor; USP8

Mesh:

Substances:

Year:  2015        PMID: 26208471     DOI: 10.1007/s40618-015-0353-0

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  40 in total

1.  Clonal composition of pituitary adenomas in patients with Cushing's disease: determination by X-chromosome inactivation analysis.

Authors:  H M Schulte; E H Oldfield; B Allolio; D A Katz; R A Berkman; I U Ali
Journal:  J Clin Endocrinol Metab       Date:  1991-12       Impact factor: 5.958

2.  Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.

Authors:  Laure Cazabat; Jérôme Bouligand; Sylvie Salenave; Michèle Bernier; Stephan Gaillard; Fabrice Parker; Jacques Young; Anne Guiochon-Mantel; Philippe Chanson
Journal:  J Clin Endocrinol Metab       Date:  2012-02-08       Impact factor: 5.958

3.  EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas.

Authors:  Hidenori Fukuoka; Odelia Cooper; Anat Ben-Shlomo; Adam Mamelak; Song-Guang Ren; Dave Bruyette; Shlomo Melmed
Journal:  J Clin Invest       Date:  2011-11-21       Impact factor: 14.808

4.  Low rate of germline AIP mutations in patients with apparently sporadic pituitary adenomas before the age of 40: a single-centre adult cohort.

Authors:  Veronica Preda; Márta Korbonits; Simon Cudlip; Niki Karavitaki; Ashley B Grossman
Journal:  Eur J Endocrinol       Date:  2014-09-02       Impact factor: 6.664

5.  Identification of epidermal growth factor mRNA-expressing cells in the mouse anterior pituitary.

Authors:  J Honda; S Oomizu; Y Kiuchi; N Komatsu; S Takeuchi; S Takahashi
Journal:  Neuroendocrinology       Date:  2000-03       Impact factor: 4.914

6.  UBPY: a growth-regulated human ubiquitin isopeptidase.

Authors:  S Naviglio; C Mattecucci; B Matoskova; T Nagase; N Nomura; P P Di Fiore; G F Draetta
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

7.  Possible role of a radiation-induced p53 mutation in a Nelson's syndrome patient with a fatal outcome.

Authors:  Emilia Modolo Pinto; Sheila A C Siqueira; Priscilla Cukier; Maria C B V Fragoso; Chin Jia Lin; Berenice Bilharinho de Mendonca
Journal:  Pituitary       Date:  2011-12       Impact factor: 4.107

8.  G-protein mutations in human pituitary adrenocorticotrophic hormone-secreting adenomas.

Authors:  E A Williamson; P G Ince; D Harrison; P Kendall-Taylor; P E Harris
Journal:  Eur J Clin Invest       Date:  1995-02       Impact factor: 4.686

9.  Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations.

Authors:  Leanne de Kock; Nelly Sabbaghian; François Plourde; Archana Srivastava; Evan Weber; Dorothée Bouron-Dal Soglio; Nancy Hamel; Joon Hyuk Choi; Sung-Hye Park; Cheri L Deal; Megan M Kelsey; Megan K Dishop; Adam Esbenshade; John F Kuttesch; Thomas S Jacques; Arie Perry; Heinz Leichter; Philippe Maeder; Marie-Anne Brundler; Justin Warner; James Neal; Margaret Zacharin; Márta Korbonits; Trevor Cole; Heidi Traunecker; Thomas W McLean; Fabio Rotondo; Pierre Lepage; Steffen Albrecht; Eva Horvath; Kalman Kovacs; John R Priest; William D Foulkes
Journal:  Acta Neuropathol       Date:  2014-05-20       Impact factor: 17.088

10.  Recurrent gain-of-function USP8 mutations in Cushing's disease.

Authors:  Zeng-Yi Ma; Zhi-Jian Song; Jian-Hua Chen; Yong-Fei Wang; Shi-Qi Li; Liang-Fu Zhou; Ying Mao; Yi-Ming Li; Rong-Gui Hu; Zhao-Yun Zhang; Hong-Ying Ye; Ming Shen; Xue-Fei Shou; Zhi-Qiang Li; Hong Peng; Qing-Zhong Wang; Dai-Zhan Zhou; Xiao-Lan Qin; Jue Ji; Jie Zheng; Hong Chen; Yin Wang; Dao-Ying Geng; Wei-Jun Tang; Chao-Wei Fu; Zhi-Feng Shi; Yi-Chao Zhang; Zhao Ye; Wen-Qiang He; Qi-Lin Zhang; Qi-Sheng Tang; Rong Xie; Jia-Wei Shen; Zu-Jia Wen; Juan Zhou; Tao Wang; Shan Huang; Hui-Jia Qiu; Ni-Dan Qiao; Yi Zhang; Li Pan; Wei-Min Bao; Ying-Chao Liu; Chuan-Xin Huang; Yong-Yong Shi; Yao Zhao
Journal:  Cell Res       Date:  2015-02-13       Impact factor: 25.617

View more
  9 in total

Review 1.  Advances and controversies in the classification and grading of pituitary tumors.

Authors:  E R Laws; D L Penn; C S Repetti
Journal:  J Endocrinol Invest       Date:  2018-06-01       Impact factor: 4.256

2.  AT-101 acts as anti-proliferative and hormone suppressive agent in mouse pituitary corticotroph tumor cells.

Authors:  B S Yurekli; B Karaca; A Kisim; E Bozkurt; H Atmaca; S Cetinkalp; G Ozgen; C Yilmaz; S Uzunoglu; R Uslu; F Saygili
Journal:  J Endocrinol Invest       Date:  2017-07-20       Impact factor: 4.256

3.  Gene mutations in Cushing's disease.

Authors:  Qi Xiong; Wei Ge
Journal:  Biomed Rep       Date:  2016-07-29

4.  Frequency of familial pituitary adenoma syndromes among patients with functioning pituitary adenomas in a reference outpatient clinic.

Authors:  N V Marques; L Kasuki; M C Coelho; C H A Lima; L E Wildemberg; M R Gadelha
Journal:  J Endocrinol Invest       Date:  2017-07-08       Impact factor: 4.256

Review 5.  Recent advances in understanding Cushing disease: resistance to glucocorticoid negative feedback and somatic USP8 mutations.

Authors:  Eleni Daniel; John Newell-Price
Journal:  F1000Res       Date:  2017-05-02

6.  Identification of a novel RASD1 somatic mutation in a USP8-mutated corticotroph adenoma.

Authors:  Andrew V Uzilov; Khadeen C Cheesman; Marc Y Fink; Leah C Newman; Chetanya Pandya; Yelena Lalazar; Marco Hefti; Mary Fowkes; Gintaras Deikus; Chun Yee Lau; Aye S Moe; Yayoi Kinoshita; Yumi Kasai; Micol Zweig; Arpeta Gupta; Daniela Starcevic; Milind Mahajan; Eric E Schadt; Kalmon D Post; Michael J Donovan; Robert Sebra; Rong Chen; Eliza B Geer
Journal:  Cold Spring Harb Mol Case Stud       Date:  2017-05

7.  The treatment with pasireotide in Cushing's disease: effect of long-term treatment on clinical picture and metabolic profile and management of adverse events in the experience of a single center.

Authors:  C Simeoli; R Ferrigno; M C De Martino; D Iacuaniello; F Papa; D Angellotti; C Pivonello; R Patalano; M Negri; A Colao; R Pivonello
Journal:  J Endocrinol Invest       Date:  2019-07-16       Impact factor: 4.256

8.  USP8 Mutations in Pituitary Cushing Adenomas-Targeted Analysis by Next-Generation Sequencing.

Authors:  Cora Ballmann; Anne Thiel; Hannah E Korah; Anna-Carinna Reis; Wolfgang Saeger; Stefanie Stepanow; Karl Köhrer; Guido Reifenberger; Christiane B Knobbe-Thomsen; Ulrich J Knappe; Ute I Scholl
Journal:  J Endocr Soc       Date:  2018-02-19

9.  CHMP1B is a target of USP8/UBPY regulated by ubiquitin during endocytosis.

Authors:  Xènia Crespo-Yàñez; Carmen Aguilar-Gurrieri; Anne-Claire Jacomin; Agnès Journet; Magda Mortier; Emmanuel Taillebourg; Emmanuelle Soleilhac; Winfried Weissenhorn; Marie-Odile Fauvarque
Journal:  PLoS Genet       Date:  2018-06-22       Impact factor: 5.917

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.